Transcription of Public Assessment Report Decentralised Procedure …
{{id}} {{{paragraph}}}
Public Assessment Report Decentralised Procedure melphalan 50 mg Powder and Solvent for Solution for Injection/Infusion ( melphalan hydrochloride) Procedure No: UK/H/6713/001/DC UK Licence Number: PL 00289/2173 TEVA UK Limited PAR melphalan 50 mg Powder and Solvent for Solution for Injection/Infusion UK/H/6713/001/DC 2 LAY SUMMARY melphalan 50 mg Powder and Solvent for Solution for Injection/Infusion ( melphalan hydrochloride, powder and solvent for injection/infusion) This is a summary of the Public Assessment Report (PAR) for melphalan 50 mg Powder and Solvent for Solution for Injection/Infusion (PL 00289/2173; UK/H/6713/001/DC). It explains how melphalan 50 mg Powder and Solvent for Solution for Injection/Infusion was assessed and its authorisation recommended, as well as its conditions of use.
PAR Melphalan 50 mg Powder and Solvent for Solution for Injection/Infusion UK/H/6713/001/DC 3 Propylene glycol may cause alcohol-like symptoms
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}